Works matching IS 09509232 AND DT 2009 AND VI 28 AND IP 38

Results: 9

Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.

Published in:

Oncogene, 2009, v. 28, n. 38, p. 3412, doi. 10.1038/onc.2009.189

By:

Dai, J.;
Peng, L.;
Fan, K.;
Wang, H.;
Wei, R.;
Ji, G.;
Cai, J.;
Lu, B.;
Li, B.;
Zhang, D.;
Kang, Y.;
Tan, M.;
Qian, W.;
Guo, Y.

Publication type:

Article

MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.

Published in:

Oncogene, 2009, v. 28, n. 38, p. 3360, doi. 10.1038/onc.2009.192

By:

Lee, K.-H.;
Chen, Y.-L.;
Yeh, S.-D.;
Hsiao, M.;
Lin, J.-T.;
Goan, Y.-G.;
Lu, P.-J.

Publication type:

Article

p21<sup>WAF1</sup> gene promoter is epigenetically silenced by CTIP2 and SUV39H1.

Published in:

Oncogene, 2009, v. 28, n. 38, p. 3380, doi. 10.1038/onc.2009.193

By:

Cherrier, T.;
Suzanne, S.;
Redel, L.;
Calao, M.;
Marban, C.;
Samah, B.;
Mukerjee, R.;
Schwartz, C.;
Gras, G.;
Sawaya, B. E.;
Zeichner, S. L.;
Aunis, D.;
Van Lint, C.;
Rohr, O.

Publication type:

Article

Genetic predisposition to human disease: allele-specific expression and low-penetrance regulatory loci.

Published in:

Oncogene, 2009, v. 28, n. 38, p. 3345, doi. 10.1038/onc.2009.194

By:

de la Chapelle, A.

Publication type:

Article

Counterbalance between RB inactivation and miR-17–92 overexpression in reactive oxygen species and DNA damage induction in lung cancers.

Published in:

Oncogene, 2009, v. 28, n. 38, p. 3371, doi. 10.1038/onc.2009.201

By:

Ebi, H.;
Sato, T.;
Sugito, N.;
Hosono, Y.;
Yatabe, Y.;
Matsuyama, Y.;
Yamaguchi, T.;
Osada, H.;
Suzuki, M.;
Takahashi, T.

Publication type:

Article

Stat3 promotes the development of erythroleukemia by inducing Pu.1 expression and inhibiting erythroid differentiation.

Published in:

Oncogene, 2009, v. 28, n. 38, p. 3349, doi. 10.1038/onc.2009.202

By:

Hegde, S.;
Ni, S.;
He, S.;
Yoon, D.;
Feng, G. S.;
Watowich, S. S.;
Paulson, R. F.;
Hankey, P. A.

Publication type:

Article

Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.

Published in:

Oncogene, 2009, v. 28, n. 38, p. 3390, doi. 10.1038/onc.2009.203

By:

Palamakumbura, A. H.;
Vora, S. R.;
Nugent, M. A.;
Kirsch, K. H.;
Sonenshein, G. E.;
Trackman, P. C.

Publication type:

Article

Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin.

Published in:

Oncogene, 2009, v. 28, n. 38, p. 3401, doi. 10.1038/onc.2009.206

By:

Wan, X.;
Kim, S. Y.;
Guenther, L. M.;
Mendoza, A.;
Briggs, J.;
Yeung, C.;
Currier, D.;
Zhang, H.;
Mackall, C.;
Li, W.-J.;
Tuan, R. S.;
Deyrup, A. T.;
Khanna, C.;
Helman, L.

Publication type:

Article

Histone macroH2A isoforms predict the risk of lung cancer recurrence.

Published in:

Oncogene, 2009, v. 28, n. 38, p. 3423, doi. 10.1038/onc.2009.26

By:

Sporn, J. C.;
Kustatscher, G.;
Hothorn, T.;
Collado, M.;
Serrano, M.;
Muley, T.;
Schnabel, P.;
Ladurner, A. G.

Publication type:

Article